🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized，multicenter, open-label Phase III, clinical study is conducted...
Status
Recruiting
Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Start Date
2023-03-03
Trial ID
NCT05586074
Treatments Being Tested
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939
This phase II, open-label, randomized trial will compare the efficacy of th...
Status
Withdrawn
Location
University of Florida
Start Date
2025-04
Trial ID
NCT05766514
Treatments Being Tested
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrollin...
Status
Terminated
Location
O'Neal Comprehensive Cancer Center
Start Date
2019-11-22
Trial ID
NCT03926624
This is an open-label, multi-cohort, multi-center Phase Ib/II clinical stud...
Status
Unknown
Location
The Affiliated Hospital of Guizhou Medical University
Start Date
2021-12
Trial ID
NCT05100303
Treatments Being Tested
This study is a multicenter, randomized, open-label, phase III clinical stu...
Status
Recruiting
Location
Anhui Provincial Hospital（The First Affiliated Hospital of U STC）
Start Date
2024-04-26
Trial ID
NCT06387069
Treatments Being Tested
The purpose of this study is to determine the clinical benefit of XY0206 th...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-06-15
Trial ID
NCT05876832
Treatments Being Tested
The primary objective of the study is to determine whether quizartinib mono...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2014-05
Trial ID
NCT02039726
Treatments Being Tested
This is a randomized，multicenter, open-label Phase III, clinical study to c...
Status
Unknown
Location
West China hospital of Sichuan University
Start Date
2021-03-24
Trial ID
NCT04716114
Treatments Being Tested